Press Releases from DelveInsight Business Research LLP (5080 total)
Hidradenitis Suppurativa Pipeline 2025 explores emerging therapies and ongoing c …
DelveInsight's, "Hidradenitis Suppurativa Pipeline Insight 2025" report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the…
Fallopian Tube Cancer Pipeline 2025 highlights the progress of novel therapeutic …
DelveInsight's, "Fallopian Tube Cancer Pipeline Insight 2025" report provides comprehensive insights about 70+ Fallopian tube cancer companies and 70+ pipeline drugs in Fallopian Tube Cancer…
Advanced Hepatocellular Carcinoma Pipeline 2025 provides an in-depth analysis of …
DelveInsight's, "Advanced Hepatocellular Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Hepatocellular Carcinoma pipeline landscape. It…
Brain Metastases Pipeline 2025 explores the evolving landscape of investigationa …
DelveInsight's, "Brain Metastases Pipeline Insights 2025" report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It…
Cutaneous T-Cell Lymphoma Pipeline Insights Report 2025: In-Depth Analysis of R& …
DelveInsight's "Cutaneous T-cell lymphoma Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Cutaneous T-cell lymphoma pipeline landscape.…
Non-Small Cell Lung Cancer Pipeline Drugs Report 2025: Unveiling the Next-Genera …
DelveInsight's, Non-Small-Cell Lung Cancer (NSCLC) Pipeline Insights 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline…
Acute Lymphocytic Leukemia Pipeline 2025: Key Insights into Novel Mechanisms, On …
DelveInsight's "Acute Lymphocytic Leukemia Pipeline Insight 2025" report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in the Acute Lymphocytic Leukemia pipeline landscape.…
Multiple Myeloma Pipeline Outlook Report 2025: A Comprehensive Review of Drugs i …
DelveInsight's "Multiple Myeloma Pipeline Insights 2025" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape.…
ESCLC Pipeline Drugs Report 2025: Exploring the Emerging Therapeutics, Innovativ …
DelveInsight's, "Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline Insight, 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Extensive-Stage Small Cell…
Epidermolysis Bullosa Pipeline Drugs 2025 Report: Uncovering Key Drug Developmen …
DelveInsight's "Epidermolysis Bullosa Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the…
Cough in Idiopathic Pulmonary Fibrosis Pipeline 2025 Report: Detailed Overview o …
DelveInsight's "Cough in Idiopathic Pulmonary Fibrosis (IPF) Pipeline Insight, 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cough in Idiopathic…
Vascular Dementia Pipeline Drugs Report 2025: Insightful Analysis of Upcoming Th …
DelveInsight's "Vascular Dementia Pipeline Insight, 2025," report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Vascular Dementia pipeline landscape. It covers the…
RIPK1 Inhibitor Pipeline Insights Report 2025: Complete Analysis of Emerging The …
DelveInsight's, "RIPK1 inhibitor Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in RIPK1 inhibitor pipeline landscape. It covers the…
HR Positive/ HER2 Negative Breast Cancer Pipeline Outlook Report 2025: Extensive …
DelveInsight's, "HR Positive/ HER2 Negative Breast Cancer Pipeline Insight, 2025," report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2…
Mesothelioma Pipeline Drugs Report 2025 Overview: Comprehensive Analysis of Clin …
DelveInsight's "Mesothelioma Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in the mesothelioma pipeline landscape. It covers the Mesothelioma…
Marginal Zone Lymphoma Pipeline Insights Report 2025 Highlights Emerging Therapi …
DelveInsight's, "Marginal Zone Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Marginal Zone Lymphoma pipeline landscape. It…
Esophageal Squamous Cell Carcinoma Pipeline Drugs Report 2025 by DelveInsight: I …
DelveInsight's "Esophageal Squamous Cell Carcinoma Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Esophageal Squamous Cell Carcinoma pipeline…
Overactive Bladder Pipeline Outlook Report 2025: Detailed Analysis of Novel Ther …
DelveInsight's "Overactive Bladder Pipeline Insights 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Overactive Bladder pipeline landscape. It covers the…
Dystrophic Epidermolysis Bullosa Pipeline Drugs Report 2025: Comprehensive Insig …
DelveInsight's, "Dystrophic Epidermolysis Bullosa Pipeline Insight, 2025," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Dystrophic Epidermolysis Bullosa pipeline landscape. It…
ER+/ HER2-VE Breast Cancer Pipeline 2025 Report by DelveInsight: Tracking Emergi …
DelveInsight "ER positive, HER2 negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the ER positive,…
Diffuse Large B-Cell Lymphoma Pipeline Drugs Report 2025: Mapping Future Therapi …
DelveInsight's "Diffuse Large B-Cell Lymphoma Pipeline Insights 2025" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Diffuse Large B-Cell Lymphoma…
Pulmonary Fibrosis Pipeline Drugs Report 2025 by DelveInsight: Latest Breakthrou …
DelveInsight's "Pulmonary Fibrosis Pipeline Insight 2025" report provides comprehensive insights about 110+ companies and 140+ pipeline drugs in the Pulmonary Fibrosis pipeline landscape. It covers…
DelveInsight's Osteoarthritis Pipeline 2025 Report: A Deep Dive into Therapies i …
DelveInsight's, "Osteoarthritis Pipeline Insights 2025" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Osteoarthritis pipeline landscape. It covers the pipeline drug…
Advanced Renal Cell Carcinoma Pipeline 2025 by DelveInsight: Comprehensive Insig …
DelveInsight's "Advanced Renal Cell Carcinoma Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline…
HER2-Positive Breast Cancer Pipeline Drugs Report 2025 Providing a Holistic View …
DelveInsight's "HER2 Positive Breast Cancer Pipeline Insight, 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in HER2 Positive Breast Cancer pipeline…
Chronic Lymphocytic Leukemia Pipeline Drugs Report 2025 by DelveInsight Offering …
DelveInsight's "Chronic Lymphocytic Leukemia Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia pipeline landscape. It…
Anal Cancer Pipeline 2025 Report by DelveInsight Highlighting Current R&D Effort …
DelveInsight's "Anal Cancer Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 8+ pipeline drugs in Anal Cancer pipeline landscape. It covers the…
Small Cell Lung Cancer Pipeline Outlook Report 2025: Comprehensive Insights into …
DelveInsight's "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Small Cell Lung Cancer…
Myelofibrosis Pipeline 2025 by DelveInsight: An In-Depth Outlook on Emerging The …
DelveInsight's, "Myelofibrosis Pipeline Insights 2025" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline…
Hepatocellular Carcinoma Pipeline Drugs Report 2025: Pharma Collaborations, Brea …
DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the…
Colorectal Cancer Pipeline Insights Report 2025: Cutting-Edge Research, Drug App …
DelveInsight's "Colorectal Cancer Pipeline Insight 2025" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the…
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2025: Key Clinical Trials, …
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insights 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It…
Niemann-Pick Type C Pipeline Drugs Report 2025 by DelveInsight: Innovative Drug …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline…
Small Cell Lung Cancer Pipeline 2025: Emerging Therapies, Novel Targets, and Ong …
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline…
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the…
Exosomes Pipeline Insights 2025: A Comprehensive Analysis by DelveInsight Highli …
DelveInsight's, "Exosomes Pipeline Insight" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Exosomes pipeline landscape. It covers the Exosomes pipeline drug…
DelveInsight's Spasticity Pipeline 2025 Report: Tracking Emerging Drugs, Key Cli …
DelveInsight's "Spasticity Pipeline Insight" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Sthe pasticity pipeline landscape. It covers the Spasticity pipeline…
Endometriosis Pipeline Drugs Report 2025: DelveInsight's In-Depth Review of Nove …
DelveInsight's, "Endometriosis Pipeline Insight" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Endometriosis pipeline landscape. It covers the pipeline drug profiles,…
Desmoid Tumors Pipeline Outlook Report 2025: Insights on Key Pharma Players, Mar …
DelveInsight's, "Desmoid Tumors Pipeline Insight 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Desmoid Tumors pipeline landscape. It covers the…
Sanfilippo Syndrome Pipeline Drugs Report 2025: Evaluating Novel Drug Candidates …
DelveInsight's, "Sanfilippo Syndrome Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Sanfilippo Syndrome pipeline landscape. It covers the…
Hunter Syndrome Pipeline Insights Report 2025: A Deep Dive into Emerging Therapi …
DelveInsight's, "Hunter Syndrome Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hunter Syndrome pipeline landscape. It covers the…
Mucopolysaccharidosis Type I Pipeline Outlook Report 2025: Comprehensive Insight …
DelveInsight's, "Mucopolysaccharidosis Type I Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Mucopolysaccharidosis Type I pipeline landscape. It…
Sandhoff Disease Pipeline Drugs Report 2025: Exploring Breakthrough Therapies, E …
DelveInsight's, "Sandhoff Disease Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Sandhoff Disease pipeline landscape. It covers the…
Essential Thrombocythemia Pipeline Outlook Report 2025: Advances in Research, Tr …
DelveInsight's, "Essential Thrombocythemia Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Essential Thrombocythemia pipeline landscape. It covers the…
Alzheimer's Disease Pipeline Assessment Report 2025: Companies, Drugs in Develop …
DelveInsight's, "Alzheimer's disease Pipeline Insight, 2025" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer's disease pipeline landscape. It covers the…
Hepatocellular Carcinoma Pipeline Drugs Report 2025: Current Trials, Key Pharma …
DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the…
Cholangiocarcinoma Pipeline Drugs Report 2025: Innovations Shaping the Future of …
DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline…
Go To Page: 1 2 3 4 5 6 7 8 9 10 51 52 53 54 55 56 57 58 59 60
